EQS-Adhoc
HOCHDORF Holding AG: Forward Integration in Baby Care
EQS Group-Ad-hoc: HOCHDORF Holding AG / Key word(s): Letter of Intent
HOCHDORF Holding AG: Forward Integration in Baby Care
25.07.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
---------------------------------------------------------------------------
HOCHDORF Holding AG: Forward Integration in Baby Care
25.07.2016 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.
---------------------------------------------------------------------------
HOCHDORF Group Press Release: Forward Integration in Baby Care
Forward integration with Pharmalys Laboratories SA under examination
Hochdorf, 25 July 2016 - HOCHDORF Holding Ltd previously announced the
integration of downstream stages of the value creation stream as one of its
strategic aims, particularly for the international market. In the area of
Baby Care there is now mutual interest with Pharmalys Laboratories SA in
pursuing an integration with the HOCHDORF Group. A Memorandum of
Understanding has been signed to this effect.
HOCHDORF Holding Ltd does not currently supply the end consumer market in
the Baby Care area through its subsidiary HOCHDORF Swiss Nutrition Ltd.
This would change with a majority shareholding in Pharmalys Laboratories
SA, based in Baar (ZG).
Active in 42 countries
The Pharmalys Group has a staff of more than 500 direct and indirect
employees around the world. The company markets infant nutrition under the
Primalac brand; it also markets infant nutrition and cereals under the
Swisslac brand. Its products are available in 42 countries in Europe, Asia,
Africa and the Middle East. Pharmalys Laboratories SA is a company that has
shown rapid growth: a HOCHDORF customer since 2008, Pharmalys expects to
achieve sales of CHF 70 million this year with a two-figure increase in the
EBIT Margins. The company is seeking to double its turnover and EBIT in the
next two years.
"We have achieved a very rapid growth in recent years with HOCHDORF
products and we would like to continue in this vein. An integration can
guarantee our access to the high-quality HOCHDORF products. In return
HOCHDORF will receive direct access to consumers in our highly attractive
markets," explained founder and CEO of the Pharmalys Group, Amir Mechria.
As part of this transaction, HOCHDORF will secure a call option for
majority share in the Dubai-based Phamena Ltd, which is also part of the
Pharmalys Group. Phamena Ltd operates exclusively in the Libyan market.
Dr Thomas Eisenring, CEO of the HOCHDORF Group is delighted with the
Memorandum of Understanding: "The HOCHDORF Group is striving towards
forward integration in the area of infant nutrition. An association with
one of our largest customers is exactly in keeping with our strategy. We
have enjoyed excellent collaboration with Pharmalys for years," he said.
The next step will be to negotiate a purchase agreement. Adoption of the
purchase agreement will depend on a variety of conditions. It may not be
derived from either the Memorandum of Understanding or this press release
that HOCHDORF Holding Ltd has acquired a minority or majority shareholding
in Pharmalys Laboratories SA either now or in the future.
End of ad hoc announcement
Additional features:
Document: http://n.eqs.com/c/fncls.ssp?u=EFBURFFCIK
Document title: HOCHDORF Group Press Release Forward Integration
---------------------------------------------------------------------------
25.07.2016 News transmitted by Tensid EQS AG. www.eqs.com
---------------------------------------------------------------------------
Information and Explanation of the Issuer to this News:
In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a
consolidated gross sales revenue of CHF 551.2 million. It is one of the
leading foodstuff companies in Switzerland, with more than 625 employees as
at 31 December 2015. Made from such natural ingredients as milk, wheat
germ, and oilseeds, HOCHDORF products have been contributing to the health
and well-being of the young and old alike since 1895. Our customers include
the food industry and wholesalers and retailers. Our products are sold in
more than 90 countries. HOCHDORF stock is traded on the SIX Swiss Exchange
in Zurich (ISIN CH0024666528).
---------------------------------------------------------------------------
Language: English
Company: HOCHDORF Holding AG
Siedereistrasse 9
6281 Hochdorf
Switzerland
Phone: +41 41 914 65 65
Fax: +41 41 914 66 66
E-mail: hochdorf@hochdorf.com
Internet: www.hochdorf.com
ISIN: CH0024666528
Listed: Foreign Exchange(s) SIX
End of News EQS Group News Service
---------------------------------------------------------------------------
485325 25.07.2016
Forward integration with Pharmalys Laboratories SA under examination
Hochdorf, 25 July 2016 - HOCHDORF Holding Ltd previously announced the
integration of downstream stages of the value creation stream as one of its
strategic aims, particularly for the international market. In the area of
Baby Care there is now mutual interest with Pharmalys Laboratories SA in
pursuing an integration with the HOCHDORF Group. A Memorandum of
Understanding has been signed to this effect.
HOCHDORF Holding Ltd does not currently supply the end consumer market in
the Baby Care area through its subsidiary HOCHDORF Swiss Nutrition Ltd.
This would change with a majority shareholding in Pharmalys Laboratories
SA, based in Baar (ZG).
Active in 42 countries
The Pharmalys Group has a staff of more than 500 direct and indirect
employees around the world. The company markets infant nutrition under the
Primalac brand; it also markets infant nutrition and cereals under the
Swisslac brand. Its products are available in 42 countries in Europe, Asia,
Africa and the Middle East. Pharmalys Laboratories SA is a company that has
shown rapid growth: a HOCHDORF customer since 2008, Pharmalys expects to
achieve sales of CHF 70 million this year with a two-figure increase in the
EBIT Margins. The company is seeking to double its turnover and EBIT in the
next two years.
"We have achieved a very rapid growth in recent years with HOCHDORF
products and we would like to continue in this vein. An integration can
guarantee our access to the high-quality HOCHDORF products. In return
HOCHDORF will receive direct access to consumers in our highly attractive
markets," explained founder and CEO of the Pharmalys Group, Amir Mechria.
As part of this transaction, HOCHDORF will secure a call option for
majority share in the Dubai-based Phamena Ltd, which is also part of the
Pharmalys Group. Phamena Ltd operates exclusively in the Libyan market.
Dr Thomas Eisenring, CEO of the HOCHDORF Group is delighted with the
Memorandum of Understanding: "The HOCHDORF Group is striving towards
forward integration in the area of infant nutrition. An association with
one of our largest customers is exactly in keeping with our strategy. We
have enjoyed excellent collaboration with Pharmalys for years," he said.
The next step will be to negotiate a purchase agreement. Adoption of the
purchase agreement will depend on a variety of conditions. It may not be
derived from either the Memorandum of Understanding or this press release
that HOCHDORF Holding Ltd has acquired a minority or majority shareholding
in Pharmalys Laboratories SA either now or in the future.
End of ad hoc announcement
Additional features:
Document: http://n.eqs.com/c/fncls.ssp?u=EFBURFFCIK
Document title: HOCHDORF Group Press Release Forward Integration
---------------------------------------------------------------------------
25.07.2016 News transmitted by Tensid EQS AG. www.eqs.com
---------------------------------------------------------------------------
Information and Explanation of the Issuer to this News:
In 2015 the HOCHDORF Group, which is headquartered in Hochdorf, generated a
consolidated gross sales revenue of CHF 551.2 million. It is one of the
leading foodstuff companies in Switzerland, with more than 625 employees as
at 31 December 2015. Made from such natural ingredients as milk, wheat
germ, and oilseeds, HOCHDORF products have been contributing to the health
and well-being of the young and old alike since 1895. Our customers include
the food industry and wholesalers and retailers. Our products are sold in
more than 90 countries. HOCHDORF stock is traded on the SIX Swiss Exchange
in Zurich (ISIN CH0024666528).
---------------------------------------------------------------------------
Language: English
Company: HOCHDORF Holding AG
Siedereistrasse 9
6281 Hochdorf
Switzerland
Phone: +41 41 914 65 65
Fax: +41 41 914 66 66
E-mail: hochdorf@hochdorf.com
Internet: www.hochdorf.com
ISIN: CH0024666528
Listed: Foreign Exchange(s) SIX
End of News EQS Group News Service
---------------------------------------------------------------------------
485325 25.07.2016
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte